Introduction
donors but not recipients were detected. Thirty-two VNBI isolates contained introgressions, 1 7 0 which was significantly more than the 14 VNI isolates and 5 VNBII isolates that contained 1 7 1 introgressions (p < 1.32×10 -5 and p < 0.0033, respectively, Fisher's exact test). Isolates with 1 7 2 introgressions included both mating types and were dispersed across the VNB phylogeny, but 1 7 3 within VNI only occurred within the African-specific subclade (Fig. 1) . Overall, introgressed 1 7 4 regions were not functionally enriched for any specific gene functions; however, the most To determine if the distinct genetic backgrounds of VNBI and VNBII, or variants identified in the 2 4 3 association analysis, correlated with any relevant phenotypes, we assayed 183 of the 186 2 4 4 sequenced VNBI and VNBII isolates for growth under a variety of stress conditions, along with a 2 4 5 set of control isolates including the VNI reference strain H99. We specifically tested response to 2 4 6 oxidative stressors H 2 O 2 and paraquat, melanization capacity with L-DOPA, and resistance to 2 4 7 the antifungal drug fluconazole (results in Supplemental Table S5 ). We did not identify any 2 4 8 isolates with mutations in stress response genes PDX3, FOX21, or FHB1 with extreme 2 4 9 response phenotypes. However, we did identify significant phenotypic differences between 2 5 0 VNBI and VNBII isolates and between clinical and environmental isolates. To control for the 2 5 1 interaction of lineage and isolation source, we analyzed only clinical isolates for lineage 2 5 2 comparisons and only VNBI isolates for isolation source comparisons. We also excluded all isolates that were completely unable to melanize in the comparison of melanization between 2 5 4 environmental and clinical isolates to prevent any effect of sampling bias (Methods). We then conducted a second GWAS analysis to identify genotypic variants associated with 2 6 6 increased or decreased responses in the phenotypic assays ( Supplemental Tables S6-S9 ).
6 7
These analyses revealed that loss-of-function mutations in BZP4 (CNAG_03346) were highly 2 6 8 associated with reduced melanization ability (p < 3.43×10 -9 , score test). Four clinical isolates, 2 6 9 two from VNBI and two from VNBII, each had a different loss-of-function mutation in BZP4.
7 0
Three of these isolates had a reduced melanization ability similar to that of a lac1 deletion 2 7 1 mutant, the primary gene required for melanization (Salas et al. 1996) , while the fourth isolate 2 7 2 showed a slightly reduced melanization potential ( Fig. 4A-C) . BZP4 was previously associated of-function of this gene is present in all VNBII isolates and could be related to the reduced 2 7 8 melanization capability of VNBII. While GWAS analysis did not produce any promising To better understand genetic diversity at the lineage level, we calculated a number of population chromosome, VNBI and VNBII appeared quite different. As shown in Fig. 5A for chromosome 5, 2 9 0 the VNI group contained long tracts of low diversity while VNBII contained predominantly high 2 9 1 diversity regions, as expected. By contrast, VNBI showed a unique pattern with high diversity 2 9 2 regions interspersed with long tracts of low diversity. These regions of low diversity correspond 2 9 3 with tracts of low Tajima's D, which suggests an excess of rare alleles resulting from a 2 9 4 population bottleneck or recent selective sweep. Confirming this, both VNI and VNBI had 2 9 5 significantly more rare alleles across the entire genome (<2% frequency) than VNBII (p<2.2×10 - In most cases, when two lineages had regions of low diversity and Tajima's D, they also had ( Supplemental Table S10 ). Overlaying these genes onto a phylogeny of all sugar transporters 3 2 7 in the reference strain H99 showed the selection was concentrated in transporters of inositol, an increased ability for VNBII isolates to colonize humans; there also may be geographic or 3 9 9 niche differences in VNBII environmental populations. Despite the fact that melanization is used 4 0 0 to identify isolates from the environment (i.e., light brown isolates are detected but pure white 4 0 1 isolates are not), it is unlikely that decreased melanization of VNBII caused the group to be 4 0 2 under-sampled as most VNBII isolates melanized to at least some degree. Further genotypic 4 0 3 and phenotypic evaluation will be required to better delineate and understand the clinical 4 0 4 ramifications of the differences between VNBI and VNBII. African isolates spread across VNIa and VNIb, the "into" hypothesis seems unlikely. More likely, 4 0 9 the three VNI sub-lineages diversified and expanded within Africa and then two were globally 4 1 0 1 7 disseminated at a later date, possibly by migration of birds and humans. Why VNI but not VNBI 4 1 1 or VNBII would be globally dispersed is unclear. While the data presented here support an 4 1 2
African origin for VNB, a small number of South America VNB isolates have been described,
including a previous analysis of nuclear loci that placed two of these isolates close to Bt22 South American VNB isolates will be required to confidently assess the origins of VNB diversity. Given the lack of overlap between the tracts of low Tajima's D and the regions identified as resolution possible with whole genome data demonstrates that many of these isolates predicted Phylogenetic analyses of the MAT alleles suggest that these alleles have followed distinct MATα allele and close relationship of the VNI MATa allele to VNBI. These observations suggest the human nervous system, and suggests many pathways to explore for differential virulence 5 0 0 within standing genetic diversity or outbreaks. We selected 387 isolates for analysis: 185 from VNI, 186 from VNB, and 16 from VNII. We and VNB, and therefore preferentially chose isolates containing MATa and those isolated from 5 0 8 environmental sources, as both are less frequently collected, particularly for VNI. We also 5 0 9
included a limited number of VNII isolates, but did not focus on this lineage as it is rarely Samples were prepared for DNA extraction as described (Supplemental Material). Genomic 5 1 6
DNA was sheared to ~250 bp using a Covaris LE instrument and adapted for Illumina Illumina HiSeq to generate 101 base reads. Reads were aligned to the C. neoformans var. For phylogenetic analysis, the 1,069,080 sites with an unambiguous SNP in at least one isolate 5 2 8 and with ambiguity in at most 10% of isolates were concatenated; insertions or deletions at 5 2 9 these sites were treated as ambiguous to maintain the alignment. Phylogenetic trees were For each phenotype, two matrices of these features were constructed from the variant calls of 5 5 0 all isolates. In the first matrix, rare variants (those at ≤ 5% frequency) were collapsed by gene or 5 5 1 intergenic region, while common variants (those at > 5% frequency) were considered 5 5 2 independently. In the second matrix, we assessed whether each gene had a loss-of-function a univariate linear mixed model and a relatedness matrix to account for population stratification. Score test results of both analyses were then combined and examined. ERG11 and AFR1 copy 5 5 7 number of drug resistant isolates were estimated as the normalized read depth of these genes Freezer stocks were grown, plates, and pinned in 1536 array format as described 5 6 4 (Supplemental Material); each single colony selected from the grown freezer stock became a 4 5 6 5 2 3
x 4 block of 16 colonies in two 1536 arrays. Four conditions were assayed: 5.6 mM H 2 O 2 , 1.0 5 6 6 mM paraquat, 10 µg/mL fluconazole, and 0.1 mg/mL L-DOPA. Arrays were incubated at 30°C 5 6 7
and images were acquired one-, two-, and three-days post pinning. Day two images were All independent experiments replicated well (R 2 , L-DOPA = 0.51, fluconazole = 0.59, paraquat = 5 7 2 0.47-0.63). We then identified differences between VNBI and VNBII clinical isolates, and VNBI 5 7 3 environmental and clinical isolates, using the Mann-Whitney U test. As C. neoformans is 5 7 4 identified in the environment (but not in the clinic) by the ability to melanize to some degree (i.e., to melanize (brightness >= 0.6) because the sampling of those isolates would be biased 5 7 8 towards clinical samples. Analyses of the mating type loci were done with the same methodology as the whole genome 5 8 2 analyses with the following two exceptions. Reads were mapped to the appropriate high quality showing branch lengths and bootstrap support for major clades; C) Linkage disequilibrium (R 2 ) 6 9 8
and diversity (π) across the MATα locus; D) Topology of the whole-genome phylogeny and with respect to VNBI (bootstrap support: 68%); F) Linkage disequilibrium (R 2 ) and diversity (π) 7 0 3 across the MATa locus. 
